FANCE

FANCE is a nuclear subunit of the Fanconi anemia (FA) core complex that functions as a molecular bridge coupling the core complex to its downstream substrate, the FANCD2-FANCI heterodimer (PMID:12093742, PMID:16127171). It binds FANCC directly and, through a distinct region, contacts FANCD2, thereby recruiting the substrate for monoubiquitination; FANCE is required for nuclear accumulation of FANCC, formation of the FANCA-FANCC complex, FANCD2 monoubiquitination, and FANCD2 nuclear foci assembly (PMID:12093742, PMID:12239156, PMID:16513431). The FANCC-binding and FANCD2-binding surfaces are separable, and the extreme C-terminal residue phenylalanine 522 is the critical determinant of the FANCD2/FANCI interaction required for substrate monoubiquitination and DNA cross-link repair (PMID:16513431, PMID:24451376). Structurally FANCE adopts a repeated helical (HEAT-like) fold, and disease-associated mutations map to this domain and disrupt the FANCE-FANCD2 interaction (PMID:17308347). Beyond its scaffolding role, FANCE is directly phosphorylated by Chk1 at threonine 346 and serine 374 upon DNA damage, an event dispensable for FANCD2 monoubiquitination but required for cross-link repair, defining a separable monoubiquitination-independent function (PMID:17296736). The FANCC-FANCE-FANCF subcomplex is evolutionarily conserved and additionally acts to suppress meiotic crossovers (PMID:36652992).

1. 1999 Medium

   Before FANCE's molecular role was known, its gene had to be localized; mapping the FA complementation group E locus established the genetic foundation for cloning and functional study.

   Evidence Homozygosity mapping and linkage analysis in FA-E families with cell fusion complementation

   PMID:10205272

   Open questions at the time

   • Does not identify the gene product or its biochemical function
   • No mechanistic role established
2. 2002 High

   It was unknown how FANCE fit into the FA pathway; demonstrating that FANCE binds FANCC and FANCD2 and is required for FANCC nuclear accumulation and FANCD2 monoubiquitination placed FANCE as an essential core complex component linking core assembly to substrate activation.

   Evidence Co-IP, nuclear fractionation, immunofluorescence, and functional rescue (MMC resistance) in FA-E cells; two independent papers

   PMID:12093742 PMID:12239156

   Open questions at the time

   • Does not define which FANCE regions mediate each interaction
   • Mechanism of how FANCE drives FANCD2 monoubiquitination not resolved
3. 2005 High

   Whether FANCE acts as a passive subunit or an active bridge was unclear; showing FANCE forms a ternary complex bridging FANCC and FANCD2, with separation-of-function mutants that bind FANCC but not FANCD2 abolishing monoubiquitination, established FANCE as the adaptor recruiting the substrate to the core complex.

   Evidence Yeast two- and three-hybrid, human cell Co-IP, random mutagenesis, and functional complementation

   PMID:16127171

   Open questions at the time

   • Does not map the residues responsible for FANCD2 binding
   • No structural basis for the bridging interaction
4. 2006 Medium

   The basis of FANCE nuclear localization was uncertain; demonstrating that nuclear accumulation depends specifically on FANCC and that FANCC- and FANCD2-binding regions are distinct refined the recruitment model.

   Evidence Fractionation, immunofluorescence, and NES fusion constructs in FA-deficient cell lines

   PMID:16513431

   Open questions at the time

   • Single lab
   • Precise NLS-independent import mechanism not defined
5. 2007 High

   The structural architecture and the question of whether FANCE has regulated functions beyond scaffolding were open; the crystal structure revealed a HEAT-like helical fold sufficient for FANCD2 binding, while Chk1 phosphorylation at T346/S374 defined a monoubiquitination-independent repair role.

   Evidence X-ray crystallography with structure-guided mutagenesis; in vitro Chk1 kinase assay, phospho-site mutagenesis, and MMC complementation

   PMID:17296736 PMID:17308347

   Open questions at the time

   • The downstream effector of Chk1-phosphorylated FANCE in cross-link repair is unidentified
   • Full-length structure in complex with partners not solved
6. 2014 High

   The exact determinant of the FANCE-FANCD2 interaction was unresolved; identifying C-terminal phenylalanine 522 as critical for FANCD2-FANCI monoubiquitination and cross-link repair pinpointed the substrate-engagement residue.

   Evidence Site-directed mutagenesis, monoubiquitination and cisplatin sensitivity assays, and dominant disruption by C-terminal fragment expression

   PMID:24451376

   Open questions at the time

   • Structural detail of the F522-FANCD2 contact not resolved
   • How this residue couples to the catalytic FANCL ligase is unclear
7. 2015 Medium

   Whether FANCE activity is endogenously regulated by isoforms was unknown; characterization of the FANCEΔ4 splice variant as a nuclear, monoubiquitination-incompetent dominant-negative that promotes FANCD2 degradation revealed an alternative-splicing layer of FANCE control.

   Evidence Retroviral expression in FANCE-deficient cells, cell cycle and viability assays, monoubiquitination immunoblot, and Co-IP

   PMID:26277624

   Open questions at the time

   • Single lab
   • Physiological regulation and prevalence of FANCEΔ4 not established
   • Mechanism of FANCD2 degradation not defined
8. 2023 Medium

   Whether the FANCC-FANCE-FANCF module has functions beyond the canonical core complex was open; showing this subcomplex is conserved to plants and acts as an anti-crossover factor in meiosis extended FANCE's role to recombination regulation.

   Evidence Genetic screen, yeast two-hybrid, and meiotic crossover analysis in Arabidopsis mutants

   PMID:36652992

   Open questions at the time

   • Demonstrated in an ortholog system, not human cells
   • Molecular mechanism of crossover suppression unresolved

• The downstream effector and molecular mechanism by which Chk1-phosphorylated FANCE promotes cross-link repair independently of FANCD2 monoubiquitination remain unidentified.
• No effector identified for the monoubiquitination-independent FANCE function
• No structure of full-length FANCE within the assembled core complex